Healthcare Realty (HR) Q1 2026 Earnings Transcript

Healthcare Realty Trust reported a record quarter with leasing activity above 2 million square feet, same-store NOI growth of 6.9%, and normalized FFO per share of $0.41, while raising full-year FFO guidance to $1.59-$1.65 and same-store cash NOI growth guidance to 3.75%-4.75%. Occupancy improved to 92.3% in same-store and 90.5% total, retention was 93.5%, and the company repurchased $100 million of stock year-to-date. Management also secured a $400 million delayed-draw term loan at roughly 4.8% all-in pricing, supporting liquidity and refinancing needs.

Analysis

HR is finally behaving like a self-help story with a catalyst stack, not just a bond-proxy REIT. The important second-order shift is that management is linking occupancy repair, longer lease terms, and higher escalators into a compounding earnings model; that matters because the market has been valuing the name as if growth were structurally capped. If they can keep total occupancy moving toward the low-90s while re-leasing at better spreads, the incremental FFO leverage should arrive faster than consensus expects, especially because most of the near-term downside from 2025 actions is now behind them.

The bigger implication is capital allocation optionality. Buybacks, JV growth, and redevelopments are not competing uses here; they are a flywheel as long as the stock trades at a material discount to private-market value and debt remains accessible below the portfolio yield. That creates an unusual setup where management can manufacture accretion three ways at once, but it also means the equity story becomes more dependent on disciplined execution and on the spread between private-market cap rates and the company’s implied valuation staying wide.

The main risk is not operating momentum; it is that the market may rerate the story faster than fundamentals, tempting management to over-rotate into financial engineering. If core sales are too aggressive, the portfolio could quietly lose some of its long-duration stability, and if financing markets tighten again the current capital-allocation cadence could slow. The near-term read-through is positive for other outpatient medical owners with similar leasing momentum, but HR is likely the cleanest expression because it has the clearest gap between current valuation and what the market typically awards to mid-single-digit organic growers.

Consensus is probably underestimating how much of the upside is timing, not just magnitude: pre-leased redevelopment and signed-not-occupied backlog can convert into occupancy over the next 2-4 quarters, which is exactly the kind of lagged inflection public REIT investors tend to miss. The stock can still trade poorly if the market dismisses this as temporary, but that gives patient capital a favorable entry point into a story with multiple visible catalysts through year-end.

Key Decisions for Investors

• Go long HR on pullbacks over the next 1-3 weeks; target a 6-12 month horizon where mid-single-digit organic growth and occupancy conversion can re-rate the multiple. Risk/reward: if the market starts pricing HR like a 14-15x FFO REIT instead of ~11x, upside is materially asymmetric versus modest fundamental downside.
• Pair trade: long HR / short a slower-growth healthcare REIT or broad REIT ETF over 3-6 months. This isolates the thesis that HR’s operating inflection and capital allocation are underappreciated relative to the sector’s typical low-growth profile.
• Use HR common or Jan-2027 calls to express the view; the key event path is multiple quarters of guidance creep as SNO and redevelopments convert into same-store NOI. Options make sense because the story is more about rerating than absolute cash yield.
• Monitor KKR as a secondary beneficiary only if the JV program scales beyond the current anchor relationship; that would support a broader private-capital channel into outpatient medical. For now, keep KKR as an indirect watchlist name rather than a primary trade.
• If HR rallies sharply on execution headlines, trim one-third to one-half into strength; the main risk is that the market prices in the easy part of the inflection before the occupancy backlog fully monetizes.